CLDF Title
Contact Us | Bookmark
HBV HCC HCV HE NASH PBC
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
      IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Pigmentary changes common with targeted anticancer agents
09-25-2017
Ontario's policy on organ donation after circulatory death boosts transplants
09-25-2017
Novelion's Aegerion resolves U.S. drug probes for $40 million
09-22-2017
How safe are various systemic therapies for pediatric psoriasis?
09-22-2017
FDA warns of death, liver injury risks from Intercept's drug Ocaliva
09-21-2017
View Complete News Library
 
 
October 20-24
AASLD 2017
Washington, DC
October 28 - Nov 1
25TH UEG Week 2017
Barcelona, Spain
View all Congresses
 
 
 
 
 
 
  Line  
  Featured Abstracts          
 
Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis Cgenotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety
 
Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome
 
The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries
 
HCV Viremic Donors With Hepatic Bridging Fibrosis: Are We Ready To Use Their Livers in The Era of Direct-Acting Antivirals?
 
Chronic hepatitis C virus infection and neurocognitive function in adult survivors of childhood cancer
 
Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study
 
 
Perinatal transmission in infants of mothers with chronic hepatitis B in California
 
Predictors of positive test results in patients with cancer undergoing hepatitis Bscreening before chemotherapy
 
Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
 
Pregnancy outcome in more than 5000 births to women with viral hepatitis: a population-based cohort study in Sweden
 
Electro-Radiological Observations of Grade III/IV Hepatic EncephalopathyPatients with Seizures
 
Ammonia Levels and Hepatic Encephalopathy in Patients with Known Chronic Liver Disease
 
 
A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis
 
Optimal treatment of hepatic encephalopathy
 
Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
 
Role of exosomes in treatment of hepatocellular carcinoma
 
Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era
 
Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma
 
 
          View All Abstracts  
  Line  
                         
 
HBV
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
 
HE
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
         
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2017 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.